Parametric Sensitivity Analysis Using Large-Sample Approximate Bayesian Posterior Distributions

References

• Anderson T. W.An Introduction to Multivariate Statistical Analysis (2003) 3rd ed.(Wiley, New York) Google Scholar
• Berenson M. L., Levine D. M., Goldstein M.Intermediate Statistical Methods and Applications (2001) (Prentice-Hall, Inc., Englewood Cliffs, NJ) Google Scholar
• Canadian Coordinating Office for Health Technology AssessmentGuidelines for Economic Evaluation of Pharmaceuticals: Canada (1997) 2nd ed.(Canadian Coordinating Office for Health Technology Assessment (CCOHTA), Ottawa, Canada) Google Scholar
• Col N. F., Goldberg R. J., Orr R. K., Erban J. K., Fortin J. M., Chlebowski R. T. Survival impact of tamoxifen use for breast cancer risk reduction: Projections from a patient-specific Markov model. Medical Decision Making (2002) 22(5):386–393Crossref, Google Scholar
• Critchfield G. G., Willard K. E. Probabilistic analysis of decision trees using Monte Carlo simulation. Medical Decision Making (1986) 6(2):85–92Crossref, Google Scholar
• Dalen J. E., Alpert J. S. Natural history of pulmonary embolism. Prog. Cardiovasc. Dis. (1975) 17(4):259–270Crossref, Google Scholar
• DeGroot M. H.Optimal Statistical Decisions (1968) (McGraw Hill, New York) Google Scholar
• Doubilet P., Begg C. B., Weinstein M. C., Braun P., McNeil B. J. Probabilistic sensitivity analysis using Monte Carlo simulation. Medical Decision Making (1985) 5(2):157–177Crossref, Google Scholar
• Felli J. C., Hazen G. B. Sensitivity analysis and the expected value of perfect information. Medical Decision Making (1998) 18(1):95–109Crossref, Google Scholar
• Felli J. C., Hazen G. B. Do sensitivity analyses really capture problem sensitivity? An empirical analysis based on information value. Risk, Decision Policy (1999) 4:79–98Crossref, Google Scholar
• Fisher B., Costantino J. P., Wickerham D. L., Redmond C. K., Kavanah M., Cronin W. M., Vogel V., Robidoux A., Dimitrov N., Atkins J., Daly M., Wieand S., Tan-Chiu E., Ford L. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J. National Cancer Inst. (1998) 90(18):1371–1388Crossref, Google Scholar
• Gail M. H., Costantino J. P., Bryant J., Croyle R., Freedman L., Helzlsouer K., Vogel V. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J. National Cancer Inst. (1999) 91(21):1829–1846Crossref, Google Scholar
• Gilks W. R., Richardson S., Spiegelhalter D. J.Markov Chain Monte Carlo in Practice (1996) (Chapman & Hall, London, UK) Crossref, Google Scholar
• Hazen G. B. Stochastic trees: A new technique for temporal medical decision modeling. Medical Decision Making (1992) 12(3):163–178Crossref, Google Scholar
• Hazen G. B. Factored stochastic trees: A tool for solving complex temporal medical decision models. Medical Decision Making (1993) 13(3):227–236Crossref, Google Scholar
• Hazen G. B. Stochastic trees and the StoTree modeling environment: Models and software for medical decision analysis. J. Medical Systems (2002) 26(5):399–413Crossref, Google Scholar
• Hazen G., Huang M. Large-sample Bayesian posterior distributions for probabilistic sensitivity analysis. Medical Decision Making (2006) 26(9):512–534Google Scholar
• Hillner B., Philbrick J. T., Becker D. N. Optimal management of suspected lower-extremity deep vein thrombosis: An evaluation with cost assessment of 24 management strategies. Arch. Intern. Med. (1992) 152(1):165–175Crossref, Google Scholar
• Ibrahim J. G., Chen M.-H., Sinha D.Bayesian Survival Analysis (2001) (Springer, New York) Crossref, Google Scholar
• National Institute for Clinical ExcellenceGuide to the Methods of Technology Appraisal (2004) (Abba Litho Sales Limited, London, UK) Google Scholar
• Reilly T. Sensitivity analysis for dependent variables. Decision Sci. (2000) 31(3):551–572Crossref, Google Scholar
• Sen P. K., Singer J. M.Large Sample Methods in Statistics: An Introduction with Applications (1994) (CRC Press, New York) Google Scholar
• Tong Y. L.The Multivariate Normal Distribution (1990) (Springer-Verlag, New York) Crossref, Google Scholar
• Vastag B. Raloxifene prevails in STAR trial, may face easier road to acceptance than previous drugs. J. National Cancer Inst. (2006) 98(11):733–735Crossref, Google Scholar
• Weinstein M. C., O’Brien B., Hornberger J., Jackson J., Johannesson M., McCabe C., Luce B. R. Principles of good practice for decision analytic modeling in health-care evaluation: Report of the ISPOR task force on good research practices-modeling studies. Value Health (2003) 6(1):9–17Crossref, Google Scholar